Pricing and packaging may differ, but the probiotic blend is the same
Interestingly, in patients with type 2 diabetes, the density of PC1/3-positive cells decreases while both the expression and density of PC-2 positive cells increases (Jorsal et al., 2018)
"Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295." JCEM
This is a major advantage
Besides diabetes and obesity management, GLP-1 drugs have shown many other potential benefits including: Lowering blood pressure Improving lipid disorders Improving fatty liver disease Reducing cardiovascular risk Decreases inflammation Reducing risk of kidney disease It is common for patients starting GLP-1 therapy to experience side effects during the first few weeks, including nausea, vomiting, headache, dizziness, and diarrhea